Remove Hospitality Remove Insurance Remove Private Equity
article thumbnail

Physician Practice Acquisitions: A Primer on Hospital & Private Equity Consolidation

InvestmentBank.com

For the better part of the last decade, physician practices have seen a wave of consolidation by hospitals and private equity with 2018 being no exception [1]. In fact, acquisitions by hospitals and private equity in provider services broke records last year according to Bain & Co’s 2019 global healthcare report.

article thumbnail

ENT & Allergy Practices Attract Private Equity

Focus Investment Banking

Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. Those specialties each have many small and independent practices, are largely hospital independent, and benefit from supply and demand tailwinds.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our List of 10 Private Equity Firms Investing in Software to Watch

Software Equity Group

For top private equity firms, there’s a lot to like about SaaS. Top Software Private Equity Firms Here is a select list of the most active PE investors in the SaaS and software industry over the past year (data taken from the SEG 2024 Annual SaaS Report ). The firm employs 93 professionals.

article thumbnail

Private Equity’s Increasing Consolidation of Oncology Practices 

Focus Investment Banking

On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a private equity group. But if you've got a [PE] backer.

article thumbnail

ENT & Allergy – 2024 Update: Conservative Pace Continues

Focus Investment Banking

Summary Private equity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Introduction Private equity groups began investing in the ear, nose, and throat and allergy space in 2018.

article thumbnail

Where Do We Stand Now as Things Start to Open Up?

Sica Fletcher

Insurance Agency & Brokerage M&A Update Many of our clients have been asking us “now that the first phase of the coronavirus pandemic seems to be ending, where do things stand with insurance brokerage M&A?” Insurance brokerage businesses can normally be viewed as predictable, basically “annuity-like” cash flows.

article thumbnail

Ophthalmology – 2024 Update: Entering a Mature Stage

Focus Investment Banking

Summary Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. More groups are now looking to add oculoplastics and other sub-specialties.